BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 33789339)

  • 1. A myeloid-stromal niche and gp130 rescue in NOD2-driven Crohn's disease.
    Nayar S; Morrison JK; Giri M; Gettler K; Chuang LS; Walker LA; Ko HM; Kenigsberg E; Kugathasan S; Merad M; Chu J; Cho JH
    Nature; 2021 May; 593(7858):275-281. PubMed ID: 33789339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
    Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
    Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.
    Brosbøl-Ravnborg A; Hvas CL; Agnholt J; Dahlerup JF; Vind I; Till A; Rosenstiel P; Höllsberg P
    Clin Exp Immunol; 2009 Mar; 155(3):487-95. PubMed ID: 19094116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CARD15/NOD2, CD14 and toll-like 4 receptor gene polymorphisms in Saudi patients with Crohn's Disease.
    Azzam N; Nounou H; Alharbi O; Aljebreen A; Shalaby M
    Int J Mol Sci; 2012; 13(4):4268-4280. PubMed ID: 22605977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crohn's disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross-tolerance to intestinal stimuli.
    Kullberg BJ; Ferwerda G; de Jong DJ; Drenth JP; Joosten LA; Van der Meer JW; Netea MG
    Immunology; 2008 Apr; 123(4):600-5. PubMed ID: 18028374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
    Schwerd T; Pandey S; Yang HT; Bagola K; Jameson E; Jung J; Lachmann RH; Shah N; Patel SY; Booth C; Runz H; Düker G; Bettels R; Rohrbach M; Kugathasan S; Chapel H; Keshav S; Elkadri A; Platt N; Muise AM; Koletzko S; Xavier RJ; Marquardt T; Powrie F; Wraith JE; Gyrd-Hansen M; Platt FM; Uhlig HH
    Gut; 2017 Jun; 66(6):1060-1073. PubMed ID: 26953272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From sensing to shaping microbiota: insights into the role of NOD2 in intestinal homeostasis and progression of Crohn's disease.
    Balasubramanian I; Gao N
    Am J Physiol Gastrointest Liver Physiol; 2017 Jul; 313(1):G7-G13. PubMed ID: 28450278
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
    Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
    Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic deletion of the bacterial sensor NOD2 improves murine Crohn's disease-like ileitis independent of functional dysbiosis.
    Corridoni D; Rodriguez-Palacios A; Di Stefano G; Di Martino L; Antonopoulos DA; Chang EB; Arseneau KO; Pizarro TT; Cominelli F
    Mucosal Immunol; 2017 Jul; 10(4):971-982. PubMed ID: 27848951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease.
    Han X; Uchida K; Jurickova I; Koch D; Willson T; Samson C; Bonkowski E; Trauernicht A; Kim MO; Tomer G; Dubinsky M; Plevy S; Kugathsan S; Trapnell BC; Denson LA
    Gastroenterology; 2009 Apr; 136(4):1261-71, e1-3. PubMed ID: 19230854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
    van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ
    Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease.
    Loganes C; Pin A; Naviglio S; Girardelli M; Bianco AM; Martelossi S; Tommasini A; Piscianz E
    World J Gastroenterol; 2016 Nov; 22(41):9117-9126. PubMed ID: 27895399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn's disease.
    Juanola O; Moratalla A; Gutiérrez A; Sempere L; Zapater P; Giménez P; Almenta I; Peiró G; González-Navajas JM; Such JF; Francés R
    J Gastroenterol; 2015 Jul; 50(7):758-68. PubMed ID: 25500977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOD2 engagement induces proinflammatory cytokine production, but not apoptosis, in leukocytes isolated from patients with Crohn's disease.
    Bodar E; Netea MG; de Jong DJ; Kullberg BJ; Joosten LA; Van der Meer JW
    Eur Cytokine Netw; 2008 Dec; 19(4):185-9. PubMed ID: 19103524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
    van Heel DA; Ghosh S; Butler M; Hunt KA; Lundberg AM; Ahmad T; McGovern DP; Onnie C; Negoro K; Goldthorpe S; Foxwell BM; Mathew CG; Forbes A; Jewell DP; Playford RJ
    Lancet; 2005 May 21-27; 365(9473):1794-6. PubMed ID: 15910952
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Schäffler H; Rohde M; Rohde S; Huth A; Gittel N; Hollborn H; Koczan D; Glass Ä; Lamprecht G; Jaster R
    World J Gastroenterol; 2018 Mar; 24(11):1196-1205. PubMed ID: 29568200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nod2 Protects the Gut From Experimental Colitis Spreading to Small Intestine.
    Al Nabhani Z; Berrebi D; Martinez-Vinson C; Montcuquet N; Madre C; Roy M; Ogier-Denis E; Dussaillant M; Cerf-Bensussan N; Zouali H; Daniel F; Barreau F; Hugot JP
    J Crohns Colitis; 2020 Jun; 14(5):669-679. PubMed ID: 31784737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing the selective estrogen receptor modulator
    Thilakasiri P; Huynh J; Poh AR; Tan CW; Nero TL; Tran K; Parslow AC; Afshar-Sterle S; Baloyan D; Hannan NJ; Buchert M; Scott AM; Griffin MD; Hollande F; Parker MW; Putoczki TL; Ernst M; Chand AL
    EMBO Mol Med; 2019 Apr; 11(4):. PubMed ID: 30885958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crohn's disease and the NOD2 gene: a role for paneth cells.
    Lala S; Ogura Y; Osborne C; Hor SY; Bromfield A; Davies S; Ogunbiyi O; Nuñez G; Keshav S
    Gastroenterology; 2003 Jul; 125(1):47-57. PubMed ID: 12851870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.